Search
Selected: All

Crystalline protein controlled release compositions

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cysteine variants of alpha interferon-2

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cysteine variants of interferon gamma

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Cysteine variants of interferon-gamma

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

DNA sequences, recombinant DNA molecules and processes for...

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

E38N interferon gamma polypeptide variants

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Effects of IFN-&ggr; on cardiac hypertrophy

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Excipient stabilization of polypeptides treated with organic sol

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Excipient stabilization of polypeptides treated with organic sol

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Flow cytometric pharmacosensitivity assay and method of cancer t

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Formulation processes for lipophilic proteins

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Formulations for protection of peg-interferon alpha conjugates

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Gamma interferon formulation

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Gene expression in mammalian cells

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Glycosylated human interferon alpha isoform

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Glycosylated interferon α

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Glycosylated interferon alpha obtained from a transgenic...

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Glycosylated interferon alpha obtained from a transgenic...

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

HCV combination therapy

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Highly purified species of human leukocyte interferon

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.